Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, said it has received a $400,000 purchase order for the company's over-the-counter products, including Glucose Rapid Spray, from Leosons General Trading Company, its marketing and distribution partner in the Middle East.
Leosons, a leading distributor of North American healthcare products in the region and the company's marketing and distribution partner in the Middle East, recently entered into a collaboration with Sheikh Saeed Bin Obaid Al Maktoum, a member of the Royal Family of United Arab Emirates. Recently, the two parties have established Medpro LLC with offices to be set up in the Dubai Healthcare City. Medpro is expected to market the company's products.
``We are excited to secure a significant purchase order in the short time since we announced our collaboration,'' said Anna Gluskin, president and chief executive officer, Generex. ``The Middle East represents a significant market due to the large number of patients with diabetes, for both Generex Oral-lyn and our OTC product line.''
Recently, Generex said that the Ministry of Health of the United Arab Emirates, Drugs Control Department issued a non-objection letter to the Imperial College London Diabetes Centre to import Generex Oral-lyn, Generex's proprietary oral insulin spray product, into Abu Dhabi. The Manager of the Drugs Control Department indicated that importation of Generex Oral-lyn can be done via the issuance of a purchase order from the Imperial College London Diabetes Centre to a drug store or pharmacy licensed by the Ministry of Health of the United Arab Emirates.
Leosons is a 25-year-old private multinational operating company in the Middle East focusing on the pharmaceutical and healthcare industry. Leosons distributes 15 healthcare-related products which are considered category leaders.